IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-gamma dependent manner.
about
Emerging role of mast cells and macrophages in cardiovascular and metabolic diseasesUp-regulation of IL-18 and IL-12 in the ileum of neonatal rats with necrotizing enterocolitisInterleukin-18.The IL18RAP region disease polymorphism decreases IL-18RAP/IL-18R1/IL-1R1 expression and signaling through innate receptor-initiated pathwaysThe pathogenic potential of Campylobacter concisus strains associated with chronic intestinal diseases.Reduced dietary omega-6 to omega-3 fatty acid ratio and 12/15-lipoxygenase deficiency are protective against chronic high fat diet-induced steatohepatitisImmunoregulation in the gut: success and failures in human disease.Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.Interleukin-18 and host defense against infection.Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: blocking interleukin 18 attenuates intestinal damage.Association between interleukin-18 gene promoter (- 607C/A and - 137G/C) polymorphisms and chronic hepatitis C virus infections: A meta-analysis.Recent developments in the pharmacological treatment of Crohn's disease.Nonredundant roles for CD1d-restricted natural killer T cells and conventional CD4+ T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of miceInterleukin-18, together with interleukin-12, induces severe acute pancreatitis in obese but not in nonobese leptin-deficient mice.Inhibition of hepatic interleukin-18 production by rosiglitazone in a rat model of nonalcoholic fatty liver disease.Targeted inhibition of IL-18 attenuates irinotecan-induced intestinal mucositis in mice.The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases.IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet.Interleukin-18 induces acute biphasic reduction in the levels of circulating leukocytes in mice.Interferon-gamma induces C/EBP beta expression and activity through MEK/ERK and p38 in T84 colon epithelial cells.Adipose tissue dysfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57BL/6 mice.Lack of Association between Interleukin 12 C(-1188)A Polymorphism and Irritable Bowel Syndrome.Chorioamnionitis induced hepatic inflammation and disturbed lipid metabolism in fetal sheep.Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake.Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men.Effect of tamoxifen on serum IL-18, vascular endothelial growth factor and nitric oxide activities in breast carcinoma patients.Gp96 Peptide Antagonist gp96-II Confers Therapeutic Effects in Murine Intestinal Inflammation.Antenatal exposure to chorioamnionitis affects lipid metabolism in 7-week-old sheep.Intestinal mononuclear cells primed by systemic interleukin-12 display long-term ability to aggravate colitis in mice.Clinical importance of serum interleukin-18 and nitric oxide activities in breast carcinoma patients.Systemic IL-12 burst expands intestinal T-lymphocyte subsets bearing the α₄ β₇ integrin in mice.Immunological characteristics and response to lipopolysaccharide of mouse lines selectively bred with natural and acquired immunities.
P2860
Q26825467-0A15EE2A-EF79-4ADD-AB1B-B6E440F73B75Q28564241-AE350C6E-434F-4D4B-BD9B-BC6B366E2CD5Q30884172-1C2DFD2B-2072-49B3-84C9-844560BCB789Q34097022-5D01DDEA-568F-4A46-BBC9-7FD601BBDBA7Q34110695-FC2842B3-6609-48E2-B3BB-ABE12E05E044Q34243636-DEBBC43D-F455-451E-8C9F-EF1E7032C1B3Q34601009-1B822AC2-53AC-404A-8B4E-2DBCABFB6853Q34779049-408DF83B-4F10-485F-9A90-B23D3E985037Q35147841-69326471-2032-4A2D-AA67-09DCA0EE7A71Q35594688-071E6C47-5757-49D7-A4F8-17C0A49CFDD1Q35645186-044FEDEA-5B9A-485B-954A-ABD0906FEBCDQ35753472-C53C921E-A6D7-4A20-AD56-9F5D2E79B872Q36370669-14C09DDD-3564-446B-A85A-66384330A6A6Q36725696-4B8CF5F2-83E8-4FBE-9A17-204C43FC9CE4Q37420086-7B16D6D3-DC00-4D72-81BF-863633F11DEEQ37719409-11719846-3FAB-47E6-B273-76FF6C120FD7Q38132555-988566FD-2E7A-4E9E-858B-6F5D7E9F405BQ39077154-7AFC5256-F146-4C20-A2C4-7F327CF82F9AQ39625918-B2A3A851-BEE0-4519-A552-E620838E7550Q40680288-2831B00D-C344-421E-93F9-B3647BFBF855Q41478592-52FCBC5C-4575-4C84-8A9D-260B4CF1492BQ42284940-397A511A-B999-4DFF-86A7-E9ACDC9AF032Q42934588-91143137-1EB1-4687-8E3A-442A93C2BC40Q43004119-A1770D53-96F2-4F85-BCD6-6B382183DFE1Q44902058-542EDA18-6BA1-4FBF-B48F-B36805B3E777Q45024315-4B10CFF3-57E5-4812-AB94-2511DB3586CCQ47221352-918AD5E7-31F6-4C65-84C1-476381E37C4EQ50763261-91471BEC-760D-4691-891E-988AC5CB3ED7Q51300945-BD4973B7-F012-48AF-BB2A-93404E26CCA5Q53387225-54CB07E7-7B58-4C43-A5E8-A464357ADEB8Q53486946-AA1D2947-48BB-42D1-9A73-3A1FD92D8BA8Q54310614-5F2A7072-F3D8-49AB-ACBA-BBFA1A1EF3F6
P2860
IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-gamma dependent manner.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
IL-18 and IL-12 induce intesti ...... an IFN-gamma dependent manner.
@ast
IL-18 and IL-12 induce intesti ...... an IFN-gamma dependent manner.
@en
type
label
IL-18 and IL-12 induce intesti ...... an IFN-gamma dependent manner.
@ast
IL-18 and IL-12 induce intesti ...... an IFN-gamma dependent manner.
@en
prefLabel
IL-18 and IL-12 induce intesti ...... an IFN-gamma dependent manner.
@ast
IL-18 and IL-12 induce intesti ...... an IFN-gamma dependent manner.
@en
P2093
P2860
P356
P1433
P1476
IL-18 and IL-12 induce intesti ...... an IFN-gamma dependent manner.
@en
P2093
Kashiwamura SI
Nakanishi K
Sekikawa K
Shimoyama T
Sugihara A
P2860
P304
P356
10.1136/GUT.47.6.779
P407
P577
2000-12-01T00:00:00Z